BRTX

Companies
NASDAQ
Biorestorative Therapies Inc.
Health Care
Price Chart
Overview

About BRTX

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Market Cap
$7.9M
Volume
65.8K
Avg. Volume
363.4K
P/E Ratio
-0.9795321
Dividend Yield
0.00%
Employees
8.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.34
Low Correlation
Volatility
High (0.95)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for BRTX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, BRTX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$7.9M
Volume65.8K
P/E Ratio-0.98
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 28, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how BRTX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025